New treatment option for Acute Lymphoblastic Leukemia, Pediatric
Official title Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia
ClinicalTrials.gov ID: NCT06722638
What this study is testing
- What it's testing
- Over 90% of children and adolescents diagnosed with acute lymphoblastic leukemia (ALL) will survive long term. Part of the successful treatment that patients receive is the delivery of chemotherapy directly into their spinal fluid via a spinal tap.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 7 and older
You may be able to join if
- Initial diagnosis of ALL or Lymphoma (as they receive the same therapy)
- In maintenance phase of treatment
- Still have 2 maintenance cycles planned
- Aged 7 and over
- Patient able to speak English
You likely can't join if
- Relapsed or refractory disease
- Previously required ultrasound guided LP procedure
- Already does LPs without anesthesia
See the full eligibility criteria
- Initial diagnosis of ALL or Lymphoma (as they receive the same therapy)
- In maintenance phase of treatment
- Still have 2 maintenance cycles planned
- Aged 7 and over
- Patient able to speak English
- Caregiver able to complete consent and study questionnaires in English or Spanish
- Relapsed or refractory disease
- Previously required ultrasound guided LP procedure
- Already does LPs without anesthesia
The study team makes the final eligibility decision.
Where it's taking place
- Washington D.C., District of Columbia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 7 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Washington D.C., District of Columbia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.